Therefore, we sought to identify novel common variants influencing adiponectin levels and test their association with risk of T2D and related metabolic traits within the framework of a large multi-ethnic consortium of GWAS. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.